Back to Search Start Over

Use of cucurbitacins for lung cancer research and therapy.

Authors :
Liu, Min
Yan, Qijia
Peng, Bi
Cai, Yuan
Zeng, Shuangshuang
Xu, Zhijie
Yan, Yuanliang
Gong, Zhicheng
Source :
Cancer Chemotherapy & Pharmacology; Jul2021, Vol. 88 Issue 1, p1-14, 14p
Publication Year :
2021

Abstract

As the main substance in some traditional Chinese medicines, cucurbitacins have been used to treat hepatitis for decades in China. Currently, the use of cucurbitacins against cancer and other diseases has achieved towering popularity among researchers worldwide, as detailed in this review with summarized tables. Numerous studies have reported the potential tumor-killing activities of cucurbitacins in multiple aspects of human malignancies. Continuous research on its anticancer activity mechanisms also brings a glimmer of light to the treatment of patients with lung cancer. In line with the promising roles of cucurbitacins against cancer, through various molecular signaling pathways, it is justifiable to propose the use of cucurbitacins as a potential mainline chemotherapy before the onset and after the diagnosis of lung cancers. Here, this article mainly summarized the findings about the biological functions and underlying mechanisms of cucurbitacins on lung cancer pathogenesis and treatment. In addition, we also discussed the safety and efficacy of their application for further research and even clinical practice. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03445704
Volume :
88
Issue :
1
Database :
Complementary Index
Journal :
Cancer Chemotherapy & Pharmacology
Publication Type :
Academic Journal
Accession number :
150496260
Full Text :
https://doi.org/10.1007/s00280-021-04265-7